NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

Not all sufferers with CLL require therapy. Regardless of all recent advancements, the iwCLL nevertheless endorses watchful observation for individuals with asymptomatic sickness.86 This suggestion is based on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (